bisbenzimidazole has been researched along with bupivacaine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lei, HY; Lu, J; Xu, R; Xu, SY; Zhang, QG | 1 |
He, Y; Ji, J; Liang, Y; Lin, Y; Liu, J | 1 |
2 other study(ies) available for bisbenzimidazole and bupivacaine
Article | Year |
---|---|
Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Anesthetics, Local; Animals; Apoptosis; Bisbenzimidazole; Bupivacaine; Cell Line; Chlorides; Gene Expression Regulation, Enzymologic; Imidazoles; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphoproteins; Pyridines; Reactive Oxygen Species | 2011 |
The Ganglioside GM-1 Inhibits Bupivacaine-Induced Neurotoxicity in Mouse Neuroblastoma Neuro2a Cells.
Topics: Animals; Apoptosis; Bisbenzimidazole; Blotting, Western; Bupivacaine; Cell Line, Tumor; Cell Survival; Flow Cytometry; G(M1) Ganglioside; Mice; Neuroblastoma; Neuroprotection; Neurotoxins; Real-Time Polymerase Chain Reaction; RNA, Messenger | 2016 |